Updated:
IPERIONX
IPERIONX was founded in 2017 by Tasos Arima in Charlotte, North Carolina.
IPERIONX
IPERIONX was founded in 2017 by Tasos Arima in Charlotte, North Carolina. The firm is structured around a proprietary molten-salt deoxygenation technology originally developed at the University of Utah, which it acquired an exclusive license to commercialize. The core proposition addresses a persistent bottleneck in the titanium industry: the inability to economically recycle titanium scrap, which forces Western manufacturers to rely on primary sponge imports from geopolitically concentrated sources. The firm's strategy centers on scaling an integrated production platform that takes titanium scrap, aluminum scrap, and titanium ore as feedstock, processing them into titanium powder and other advanced metal products. The target markets are additive manufacturing, aerospace, defense, and medical implants. IPERIONX has publicly communicated a modular production model, where manufacturing facilities co-locate with scrap-generating industrial ecosystems. The firm's pilot facility in Utah has produced material that met ASTM International specifications for titanium powder, and the company has entered into supply-chain qualification programs with aerospace OEMs. In September 2023, IPERIONX completed a reverse merger with a publicly listed special purpose acquisition company to list on the Nasdaq under the ticker IPX. The transaction was intended to fund the construction of IPERIONX's first commercial-scale production facility. The public listing makes IPERIONX one of only a small number of dedicated titanium-powder producers accessible to public-market allocators. The firm maintains its operational base in North Carolina, with research ties to the University of Utah's metallurgical engineering department. Unlike traditional titanium sponge producers that are vertically integrated upstream into mining, IPERIONX sits downstream of scrap generation and upstream of component manufacturing — a midstream processing posture. The process uses less energy than the Kroll method that dominates titanium production, and the feedstock flexibility allows the economics to decouple partially from ilmenite and rutile concentrate prices. This architecture positions the firm as a recycling-centric supplier in a metal system where circularity has historically been negligible.
General information
Firm type
Asset Manager
Year founded
2017
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Charlotte
Corporate office
Charlotte, NC, United States
Principals
Anastasios (Tasos) Arima
Founder & CEO
Sector focus
Frequently asked questions
What is IPERIONX's core technology and why does it matter for titanium supply chains?
IPERIONX holds an exclusive license to a molten-salt deoxygenation process developed at the University of Utah. The technology strips oxygen from titanium scrap and low-grade feedstocks, producing powder that meets ASTM specifications for aerospace and medical applications. This matters structurally because the titanium supply chain remains heavily dependent on Russian (VSMPO-AVISMA) and Chinese sponge producers, with limited economical recycling pathways in the West. The process operates at lower temperatures than the dominant Kroll method, offering a lower-energy route to powder production.
How does IPERIONX source its titanium feedstock?
The firm's process is designed to accept three input streams: titanium scrap from industrial sources, aluminum scrap as a reducing agent, and titanium ore concentrates. By positioning production facilities near scrap-generating manufacturing clusters, IPERIONX aims to tap into a waste stream that has historically been downgraded into ferrotitanium for steel alloys or landfilled. This feedstock flexibility is central to the firm's unit economics and supply-chain resilience pitch.
What end markets does IPERIONX target?
The primary markets are titanium powder for additive manufacturing, aerospace structural components, defense applications, and medical implants. Titanium powder is a growth input for 3D-printed orthopedic devices and aircraft brackets where buy-to-fly ratios make near-net-shape printing economically compelling. IPERIONX has indicated it is pursuing qualification processes with aerospace OEMs, which is the rate-limiting step for any new titanium powder entrant.
Is IPERIONX a pre-revenue company, and how is it funded?
As of its 2023 Nasdaq listing via SPAC merger, IPERIONX was pre-revenue at commercial scale, having produced qualification-grade material from its Utah pilot facility. The public listing was structured to fund the construction of the first commercial-scale manufacturing plant. Being publicly listed means the firm's capital allocation and project timelines are visible through SEC filings, which is unusual among early-stage materials-technology companies that typically remain venture-backed.
What is IPERIONX's relationship with the University of Utah?
IPERIONX's foundational intellectual property was developed in the metallurgical engineering department at the University of Utah, and the firm operates under an exclusive license from the university. This academic lineage is material because the molten-salt deoxygenation process is a known research pathway in extractive metallurgy, and the university relationship provides a pipeline for ongoing process optimization talent.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: